Gastrointestinal pharmacoradiology, an updated review of medications and gastrointestinal contrasts in abdominal imaging
- PMID: 39225719
- DOI: 10.1007/s00261-024-04504-4
Gastrointestinal pharmacoradiology, an updated review of medications and gastrointestinal contrasts in abdominal imaging
Abstract
The purpose of this article is to review commonly used medications in abdominal radiology including their indications, mechanisms of action, dosages, contraindications, precautions, and adverse reactions. We will clarify common inquiries and address frequently asked questions by patients and clinicians related to their use. In addition, we will explore the indications, advantages and disadvantages, dosages, and contraindications of enteric contrast agents used for CT and fluoroscopic examinations.
Keywords: Abdominal imaging; Contrast; Medication; Pharmacoradiology.
© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
References
-
- Song GM, Tian X, Ma L, Yi LJ, Shuai T, Zeng Z, Zeng XT (2016). Regime for Bowel Preparation in Patients Scheduled to Colonoscopy: Low-Residue Diet or Clear Liquid Diet? Evidence From Systematic Review With Power Analysis. Medicine (Baltimore). https://doi.org/10.1097/MD.0000000000002432 . - DOI - PubMed - PMC
-
- Liu LW (2011). Chronic constipation: current treatment options. Can J Gastroenterol 25 Suppl B:22B-28B.
-
- Keedy AW, Yee J, Aslam R, Weinstein S, Landeras LA, Shah JN, McQuaid KR, Yeh BM (2011). Reduced cathartic bowel preparation for CT colonography: prospective comparison of 2-L polyethylene glycol and magnesium citrate. Radiology 261:156–164. https://doi.org/10.1148/radiol.11110217 - DOI - PubMed - PMC
-
- Saltzman JR, Cash BD, Pasha SF, et al (2015). Bowel preparation before colonoscopy. Gastrointest Endosc 81:781–794. https://doi.org/10.1016/j.gie.2014.09.048 - DOI - PubMed
-
- Nobutomo Ikarashi, Kohta Baba, Takashi Ushiki, Risako Kon, Ayako Mimura, Takahiro Toda, Makoto Ishii, Wataru Ochiai, and Kiyoshi Sugiyama (2011). The laxative effect of bisacodyl is attributable to decreased aquaporin-3 expression in the colon induced by increased PGE2 secretion from macrophages. American Journal of Physiology-Gastrointestinal and Liver Physiology 301:G887-G895. https://doi.org/10.1152/ajpgi.00286.2011 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
